Global InformationWilliam Rastetter information
William Rastetter | |
|---|---|
 Rastetter in 2018 | |
| Born | William Harry Rastetter[2] 1948 Panama[3] |
| Nationality | American |
| Alma mater | MIT, Harvard |
| Awards | Biotechnology Heritage Award[1] |
| Scientific career | |
| Fields | Biotechnology, Venture capitalism |
| Doctoral advisor | Robert Burns Woodward |
William H. (aka Bill) Rastetter (born 1948), a scientist, entrepreneur and venture capitalist, is the chair of Neurocrine Biosciences, of Fate Therapeutics,[4] and of Daré Bioscience, Inc.[5] in San Diego, California. He is a founding board member and investor in GRAIL, Inc. in Menlo Park, California, and served for a period as the company's interim CEO (2017) and chair (2017-2018).[6][7][8] Rastetter is also a director of Regulus Therapeutics[9] and Entos, Inc.. He was a partner in the venture firm Venrock (2006-2013),[4] and a trustee at Caltech (2015-2018).[10][11] He has served as a director (1998-2016) and as chair of Illumina (2005-2016).[4] He advised SVB Leerink[12] (2014-2019) and currently advises Illumina Ventures (since 2016).[13][4]
Between 1986 and 2003, Rastetter held positions as President, Chief Executive Officer, Chief Financial Officer and director at IDEC Pharmaceuticals.[4] At IDEC, Rastetter was a co-inventor of and developed Rituxan, the first monoclonal antibody (MAB) to be approved by the U.S. FDA for cancer therapy.[14][15] In 2003, Idec merged with Biogen to form the third largest biotech firm in the United States. Rastetter was Executive Chair of the new company, Biogen IDEC, from 2003 to 2005.[4][16]
Rastetter was also a co-founder, interim CEO and chairman of Receptos, Inc. a biopharmaceutical company which was bought by Celgene Corporation in 2015.[4][17][18]
Rastetter has been described as an "omnipotent biotech force"[13] and by Alnylam Pharmaceuticals CEO John Maraganore as an "industry legend" who has deep biotechnology expertise.[9]
- ^ Cite error: The named reference
Science History Institutewas invoked but never defined (see the help page). - ^ Cite error: The named reference
Engagedwas invoked but never defined (see the help page). - ^ Cite error: The named reference
Phillipswas invoked but never defined (see the help page). - ^ a b c d e f g Cite error: The named reference
Bloombergwas invoked but never defined (see the help page). - ^ Cite error: The named reference
DAREwas invoked but never defined (see the help page). - ^ Cite error: The named reference
GrailCEOwas invoked but never defined (see the help page). - ^ Cite error: The named reference
Meilingwas invoked but never defined (see the help page). - ^ Keown, Alex (December 14, 2017). "GRAIL Poaches New CEO From Roche, Genentech". BioSpace. Retrieved 2 May 2019.
- ^ a b Cite error: The named reference
Reguluswas invoked but never defined (see the help page). - ^ Cite error: The named reference
Fesenmaierwas invoked but never defined (see the help page). - ^ Cite error: The named reference
Trusteeswas invoked but never defined (see the help page). - ^ Cite error: The named reference
LEERINKwas invoked but never defined (see the help page). - ^ a b Cite error: The named reference
Prestonwas invoked but never defined (see the help page). - ^ Cite error: The named reference
Shindellwas invoked but never defined (see the help page). - ^ Cite error: The named reference
CLSAwas invoked but never defined (see the help page). - ^ Cite error: The named reference
Thayerwas invoked but never defined (see the help page). - ^ Cite error: The named reference
Timmermanwas invoked but never defined (see the help page). - ^ Cite error: The named reference
Berkrotwas invoked but never defined (see the help page).